Tiantian Liu

15PUBLICATIONS
88CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 26, 2026
ID2 secures cDC1 specification by antagonizing E proteins at a pleiotropic Zeb2 enhancer.

|Jul 31, 2026
Two differentiation pathways generate large peritoneal macrophages with one replenishing mesothelial border macrophages.

|Sep 15, 2025
ID2 secures cDC1 specification by antagonizing E proteins at a pleiotropic Zeb2 enhancer.

Feiya Ou, Tian-Tian Liu, Siling Du

|Aug 15, 2025
Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.

Graham D Hogg, Alyssa G Weinstein, Natalie L Kingston

|May 30, 2025
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.

Miguel Galán, Laura Fernández-Méndez, Vanessa Núñez

|Feb 07, 2025
Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2.

Suin Jo, Ray A Ohara, Derek J Theisen

Pageof 3

Frequent Collaborators

12 joint publications

Kenneth Murphy

6 joint publications

Feiya Ou

5 joint publications

Ray A Ohara

4 joint publications

Stephen T Ferris